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Background: VAAM is an amino acid mixture that simulates the composition of Vespa larval saliva. VAAM enhanced
physical endurance of mice and have been used by athletes as a supplementary drink before exercise. However,
there is no information on the effect of VAAM on the physiology of freely moving animals. The purpose of this
study was to obtain information about the VAAM-dependent regulation of liver and adipose tissue transcriptomes.
Results: Mice were orally fed a VAAM solution, an amino acid mixture mimicking casein hydrolysate (CAAM) or
water under ad libitum feeding conditions for 5 days. Comparisons of the hepatic transcriptome between VAAM-,
CAAM-, and water-treated groups revealed a VAAM-specific regulation of the metabolic pathway, i.e., the
down-regulation of glycolysis and fatty acid oxidation and the up-regulation of polyunsaturated fatty acid synthesis
and glucogenic amino acid utilization. Similar transcriptomic analyses of white and brown adipose tissues (WAT and
BAT, respectively) indicated the up-regulation of phospholipid synthesis in WAT and the negative regulation of
cellular processes in BAT. Because the coordinated regulation of tissue transcriptomes implied the presence of
upstream signaling common to these tissues, we conducted an Ingenuity Pathways Analysis. This analysis showed
that estrogenic and glucagon signals were activated in the liver and WAT and that beta-adrenergic signaling was
activated in all three tissues.
Conclusions: We found that VAAM ingestion had an effect on multiple tissue transcriptomes of freely moving
mice. Utilization of glycogenic amino acids may have been activated in the liver. Fatty acid conversion into
phospholipid, not to triacylglycerol, may have been stimulated in adipocytes contrasting that a little effect was
observed in BAT. Analysis of upstream factors revealed that multiple hormonal signals were activated in the liver,
WAT, and BAT. Our data provide some clues to understanding the role of VAAM in metabolic regulation.
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The amino acid composition of food has a large impact
on the metabolic homeostasis of individuals, especially
when they are supplied as a major nutrient. As clearly
understandable by the polyribosome model of protein syn-
thesis, a shortage of the first-limiting amino acids readily
affects the supply of proteins as the source of enzymes and
other tissue-constructing materials. In this regard, essential
amino acids (EAAs) are critical for the growth of the ani-
mal owing to their inability to synthesize EAAs from an or-
ganic backbone and nitrogen donor. In addition, many
amino acids possess organic acid moieties that can serve as
substrates for energy production (glucogenic and ketogenic
amino acids).
In addition to these nutritive functions of amino acids,
some dietary amino acids play roles as extracellular sig-
nals. Branched chain amino acids (BCAAs) constitute
approximately 50 % of dietary EAAs and are known to
activate protein anabolism via the mammalian target of
rapamycin (mTOR)-dependent pathway [1, 2]. Glycine,
glutamate, phenylalanine, histidine, and tryptophan act
as or are metabolized to neurotransmitters and thus are
able to exert a modulatory effect on the nervous system
[3]. Portions of gastrointestinal epithelial cells express L-
amino acid-sensing taste receptors and stimulate gastro-
intestinal hormone secretion in response to phenylalan-
ine, leucine, glutamate, and tryptophan administration
[4, 5]. These non-nutritive functions are attributable to a
small number of amino acids but not to their whole con-
stituent amino acids.
We have investigated the regulatory role of an amino
acid mixture that simulates Vespa species (VAAM) on
motor performance in animals at the dosing condition of
sub-nutritional level (0.38 % of total food-derived energy/
day). VAAM consists of 17 amino acids, among which gly-
cine, tryptophan, and proline are present at an approxi-
mately twofold higher molar ratio than diet-derived amino
acids (Additional file 1: Table S1). We first searched the
optimum condition of VAAM administration to achieve
significant enhancement of exercise performance [6]. In
one study, a preceding oral administration of VAAM at
the dose of 0.67 g/kg body weight improved the swimming
performance of mice; this improvement was not observed
with an amino acid mixture simulating the amino acid
composition of bovine casein (CAAM) [7]. In addition,
VAAM can lower serum lactate levels and activate fatty
acid release into mice sera and into the media of cultured
rat adipocytes [6, 8]. VAAM solution, as a sport supple-
ment drink, has been in product line since 1995 and
consumed by many athletes. In the human studies, the
preceding administration of VAAM at the dose of one
eighth of our animal studies significantly lowered the re-
spiratory quotient during the 60 min of cycling exercise
[9], and the 12 weeks of VAAM administration at the samedose as above increased maximal oxygen uptake in the
older women groups [10]. These results suggest that
ingested VAAM may affect the metabolic state of mul-
tiple tissues, such as liver and adipose tissues, to facili-
tate energy supply to the locomotor system. However,
there is no information on the effect of VAAM on the
physiology of resting or freely moving animals. Here we
present data indicating this type of regulation in mul-
tiple tissues at the gene transcriptional level.Results
Characterization of genes regulated by VAAM
administration in murine liver
Mice under freely feeding and freely moving conditions
were treated with VAAM, CAAM, or water once per day
for 5 days and euthanized at 4 h after the last administra-
tion (Additional file 2: Figure S1). The energy contribution
of VAAM and CAAM was 0.38 % of total food-derived en-
ergy/day (Additional file 1: Table S1). The biochemical
analysis of mice sera showed no difference in terms of car-
bohydrates and lipids among the groups (Additional file 3:
Table S2). We conducted DNA microarray analysis to in-
vestigate the physiological effect of VAAM administration.
The differentially expressed genes (DEGs) were calculated
by the statistic comparison between the water group
and VAAM group or between the water group and
CAAM group (see “Methods”). These DEGs were then
set-theoretically subtracted or merged to extract DEGs
specifically regulated by VAAM administration (Fig. 1).
To elucidate the function of genes regulated by VAAM
specifically, we applied GO analysis to the subset of the
extracted genes. The group specifically up-regulated by
VAAM administration was composed of 446 genes, 217
down-regulated genes, and 45 plus 15 genes inversely
correlated among VAAM and CAAM, as shown in a
Venn diagram (Fig. 1a, b). The GO terms attributed to
these probe sets clearly indicate that the genes related
to lipid metabolism are significantly enriched in these
subsets (Fig. 2). It is also notable that 45 + 15 genes,
which were oppositely regulated by VAAM and CAAM,
respectively (Fig. 1b), include eight genes (cytochrome
P450, family 7, subfamily b, polypeptide 1 (Cyp7b1),
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and
steroid delta-isomerase 5 (Hsd3b5), phosphatidylcho-
line transfer protein (Pctp), sterol regulatory element bind-
ing transcription factor 1 (Srebf1), aldehyde dehydrogenase
family 3, subfamily A2 (Aldh3a2), fatty acid binding protein
7, brain (Fabp7), 3-hydroxy-3-methylglutaryl-Coenzyme A
synthase 1 (Hmgcs1), and retinol dehydrogenase 9 (Rdh9))
related to lipid metabolism; three genes (serine hydroxy-
methyltransferase 1 (soluble) (Shmt), solute carrier family
46, member 1 (Slc46a1), and thiopurine methyltransferase
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Fig. 1 Effects of amino acid mixtures on tissue transcriptomes. a Number of genes regulated by VAAM and/or CAAM. VAAM Up or CAAM Up:
up-regulated compared with the water group; VAAM Down or CAAM Down: down-regulated compared with the water group. b Number of
regulated genes in the liver, WAT, and BAT
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glycolysis (Additional file 4: Table S3).
Regulation of liver metabolism by VAAM
Mapping of the enriched genes to known metabolic
pathways revealed a VAAM-specific regulation of lipid
and amino acid metabolism, i.e., a down-regulation of
beta- and omega-oxidation (Fig. 3a), the accumulation of
middle chain fatty acid (Fig. 3b), the utilization of
cholesterol stock for bile acid synthesis (Fig. 3c), and the
utilization of glucogenic amino acids in the TCA cycle
(Additional file 5: Table S4) (Fig. 3d). In particular, the
oppositely regulated genes highlight the VAAM-specific
effect on metabolic pathways; e.g., Hmgcs1 and Cyp7b1
in bile acid synthesis (Fig. 3a) and Pklr and Shmt inGO:ID Term
0008152 metabolic process
0044237 cellular metabolic proces
0042180 cellular ketone meta
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Fig. 2 Gene ontology analysis of liver genes for which expression levels we
Fig. 1b were used for analysis. GO terms located at the bottom of hierarchyglucogenic amino acid utilization (Fig. 3d). We confirmed
expression levels of Elovl3 (elongation of very long chain
fatty acids like 3), Pecr (peroxisomal trans-2-enoyl-CoA re-
ductase), and G6pc (glucose-6-phosphatase, catalytic sub-
unit) by quantitative PCR and found that Elovl3 and Pecr
were down-regulated in the VAAM group, while G6pc was
up-regulated in the VAAM group as observed in DNA
microarray analysis (Additional file 6: Figure S2).
Response of adipose tissue transcriptomes to VAAM
Next, we applied a similar transcriptomic analysis to
white and brown adipose tissues (WAT and BAT). In the
case of WAT, the GO terms attributed to the VAAM-
responsive genes (354 + 140 + 12 + 231 genes, Fig. 1a, b)
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Fig. 3 (See legend on next page.)
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(See figure on previous page.)
Fig. 3 Metabolic function of VAAM-regulated genes in the liver and WAT. Gene symbols and their mode of regulation by VAAM (black arrows), by
CAAM (white arrows), and by VAAM and CAAM (gray arrows) are represented in fatty acid oxidation (a), in fatty acid desaturation (b), in cholesterol
metabolism (c), and in glycolysis, glucogenic amino acid metabolism, and the TCA cycle (d) in the liver. e Glucose and triacylglycerol metabolism
of WAT. All gene symbols and their full names are listed in Additional file 5: Table S4
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ylic acid metabolism process” (Fig. 4). Approximately,
one half of the genes enriched in “monocarboxylic acid
metabolism process” were related to lipid synthesis (17
out of 30, Additional file 7: Table S5). Mapping these
genes in metabolic pathways revealed that VAAM up-
regulates several genes for phospholipid synthesis from
glucose and fatty acid (Fig. 3e). Four genes for enzymes of
acylglycerol synthesis were oppositely regulated: up-
regulated for monoacylglycerol O-acyltransferase 1 (Mogat1)
and diacylglycerol O-acyltransferase 1 (Dgat1), and down-
regulated for monoacylglycerol O-acyltransferase 2 (Mogat2)
and diacylglycerol O-acyltransferase 2 (Dgat2). It is also not-
able that solute carrier family 37 (glucose-6-phosphate
transporter), member 4 (Slc37a4), which facilitates glucose-
6-phosphatase activity, is up-regulated.
GO analysis of VAAM-responsive genes in BAT (271 +
97 + 21 + 440 genes, Fig. 1a, b) resulted in the identification
of the term “negative regulation of biological process” lo-
cated at the bottom of the hierarchy (Fig. 5). These terms
contain a smaller number of metabolic enzyme genes than
is the case for liver and WAT, but those related to cellular
signaling such as adiponectin receptor 2 (Adipor2), adeno-
sine A1 receptor (Adora1), cyclin-dependent kinase inhibi-
tor 1 (Cdkn1), glycogen synthase kinase 3b (Gsk3b), protein
tyrosine phosphatase, non-receptor type (Ptpn), forkhead
box O1 (Foxo1), insulin-like growth factor 1 (Igf1), lympho-
cyte protein tyrosine kinase (Lck), mitogen-activated pro-
tein kinase (Mapk), and regulator of G-protein signaling
(Rgs) (Additional file 8: Table S6). This finding prompted
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Fig. 4 Gene ontology analysis of WAT genes for which expression levels w
Fig. 1b were used for analysis. GO terms located at the bottom of hierarchyregulate the adipose tissue transcriptomes in relation to
that of the liver.
Search for upstream regulators common among liver and
adipose tissues
We searched for Ingenuity Pathway Analysis (IPA) up-
stream regulators of VAAM-regulated genes starting
with liver genes (446 + 217 genes), followed by compari-
son with the WAT genes (354 + 231 genes) and the BAT
genes (271 + 440 genes), respectively. The liver transcrip-
tome exhibited a total of 103 activated and 32 inhibited
upstream regulators (absolute Z-scores >2.0, Table 1).
Because some of these regulators have close functional
relationships to each other, they were classified into the
same columns (e.g., “isoproterenol”, “norepinephrine” as
a beta-agonist, and “propranolol” as a beta-antagonist).
Interestingly, there are obvious inter-tissue correlations
of selected regulators, including “norepinephrine” (2.06
in WAT and 3.05 in BAT) and “progesterone” (Z-score
of 2.50 in liver and 2.12 in WAT). Considering the func-
tional similarity of these selected regulators, it is very
possible that beta-adrenergic and TGF-related signals
may be activated in these three tissues. It is also note-
worthy that estrogen, glucagon, and gentamicin signals
seemed to be activated in the liver and WAT and that I-
kappa B, interleukins 5 and 6, insulin, PDGF, and the
other signals were activated in BAT and WAT (Table 1).
There was a discrepancy in the Z-score between “INS”,
at −2.18 in the liver, and “Ins1”, at 2.23 in BAT. The
mouse genome contains two genes for insulin (Ins1
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GO:ID Term Count FDR-corrected 
p-value
0065007 biological regulation - -
0050789 regulation of biological process - -
0048519 negative regulation of biological process 113 5.2E-03
Fig. 5 Gene ontology analysis of BAT genes for which expression
levels were affected by VAAM administration. 271 + 97 + 21 + 440
genes in Fig. 1b were used for analysis. GO terms located at the
bottom of hierarchy are represented by shaded text
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that this discrepancy is due to functional differences be-
tween the Ins1 and Ins2 genes.
Discussion
In this study, we examined the non-nutritive effect of a
specific amino acid mixture, VAAM, on the liver, WAT,
and BAT transcriptomes in mice under freely moving
conditions. From the gene ontology (GO) analysis of
VAAM-regulated genes, it was predicted that VAAM
may up-regulate sugar and lipid anabolism in these tis-
sues. In addition, a comparative analysis of IPA upstream
factors among these tissues suggested that estrogenic
and glucagon signals were activated in the liver and
WAT and that beta-adrenergic signaling was activated in
the three tissues.
Our previous studies [6, 7] on VAAM were conducted
using a mouse model under forced exercise conditions,
where the glycogen storage might have been exhausted
and the muscle might have continued to move with the
help of a fatty acid supply from the adipose tissues. The
major difference between the previous studies and the
present study resides in whether or not moving condi-
tions were present (forced swimming or free motion)
and in the dosing condition (one shot or five shots).
However, there are some correlations in the metabolic
regulation among these studies. We observed a down-
regulation of beta-oxidation and an up-regulation of gluco-
genic amino acid utilization in the liver (Fig. 3). The former
may save the fatty acid pool in total and the latter makes it
possible to supply amino acid-derived substrates to gluco-
neogenesis in response to exercise stimulus [11–13]. In the
case of WAT, four enzyme genes for acylglycerol synthesis
were regulated in a distinct manner: Mogat1 and Dgat1
were up-regulated, and Mogat2 and Dgat2 were down-
regulated. Especially, the opposite regulation of Dgat1 (up)
and 2 (down) should be mentioned because Dgat1 facili-
tates fatty acid/acylglycerol shuttling, and Dgat2 is respon-
sible for triacylglycerol accumulation [14]. This regulation
may support fatty acid release to the serum. It is also pos-
sible that the up-regulation of Slc37a4 may decrease lactate
production by facilitating glucose regeneration from
glucose-6-phosphate (Fig. 3e). The role of BAT in exercise
performance is not clear because our experiments were
performed at a moderate temperature, where no additionalthermogenesis is required. However, it should be noted
that the two catecholamine responsive genes, deiodinase,
iodothyronine, type II (Dio2) and peroxisome proliferator-
activated receptor gamma, coactivator 1 alpha (Ppargc1a,
also known as Pgc1a), are up-regulated. These genes are re-
ported to be induced in mice and rats exposed to cold
temperature [15, 16]. In the moderate temperature condi-
tion as those we adopted, this kind of regulation may result
in an increased basal metabolic rate under resting condi-
tions [12, 17, 18]. In conclusion, the VAAM-dependent
regulation of multiple tissue transcriptomes seems to be a
tuning mechanism that makes the metabolic state resistant
to more intense exercise. It would be valuable to examine
the effect of middle term (approximately 1 week) pre-
administration of VAAM on exercise performance in a hu-
man interactive study.
Whether VAAM acts on these tissues directly or indir-
ectly is an open question. From the IPA upstream factor
analysis, it was predicted that the three endocrine factors
adrenaline, estrogen, and glucagon seemed to stimulate
these tissues. In particular, adrenaline is the most plausible
factor involved in VAAM signaling because several IPA
terms related to adrenergic signals were detected in the
three tissues (Table 1) and its increase in the mice sera was
detected in a previous study [7]. Considering that a major
source of adrenaline is the hypothalamus-sympathetic
nerve-adrenal medullary (HSA) axis, we think it is highly
possible that VAAM controls terminal tissues via this sys-
tem. This assumption raises another question as to what
type of mechanism transduces VAAM signals in the HSA
axis. There are two supporting information. First is that
VAAM’s effect depends on the overall ratio of amino acids
(Additional file 1: Table S1), and second, the maximal effect
of VAAM was obtained with the pretreatment of animals
30 min before the exercise. These considerations suggest
that the sensing mechanism for VAAM might have a broad
spectrum to amino acids and that the mechanism may res-
ide in the gastrointestinal tract that faces the VAAM solu-
tion but not in metabolizing tissues nor locomotor systems.
Accordingly, we assume that gastrointestinal chemosensory
cells are one of the candidate targets of VAAM stimulus.
Further investigation is needed to elucidate the VAAM-
sensing and VAAM-transducing machinery.Conclusions
We found that VAAM ingestion had an effect on multiple
tissue transcriptomes of freely moving mice. Utilization of
glucogenic amino acids may have been activated in the
liver. Fatty acid conversion into phospholipid, not to triac-
ylglycerol, may have been stimulated in adipocytes con-
trasting that a little effect was observed in BAT. Analysis of
upstream factors revealed that multiple hormonal signals
were activated in the liver, WAT, and BAT. Our data
Table 1 Correlation of IPA upstream regulators between the liver, WAT, and BAT transcriptomes
IPA upstream regulator VAAM CAAM
Liver WAT BAT Liver WAT BAT
Isoproterenol 2.87 1.10 0.34 
Norepinephrine 1.97 2.06 3.05 0.09 
Propranolol -2.22 1.99 
GDF2 2.60 2.40 0.05 0.99 -2.17
INHA 0.40 -2.31 1.11 0.38 
Tgf beta 1.84 2.25 0.78 0.00 1.21 
TGFB1 3.63 0.25 0.90 0.29 -3.57 -3.09
17-Alpha-ethinylestradiol 0.30 2.40 1.93 0.97 -2.36
Beta-estradiol 2.41 1.54 0.13 0.29 0.45 0.24 
ESR1 3.51 0.08 0.43 1.12 
Estrogen 0.66 2.24 0.86 0.92 1.77 
Estrogen receptor 2.36 0.75 0.82 0.18 
Progesterone 2.50 2.12 0.49 0.17 0.62 0.29 
GCG 2.77 0.40 
Glucagon 2.62 1.13 
Gentamicin 2.20 0.35 0.51 0.72 0.41 0.46 
Gentamicin C 2.65 1.89 1.13 
Cocaine 3.09 2.22 0.71 
CHUK 2.18 0.20 3.25 1.08 0.83 
IKBKB 2.88 0.41 2.25 1.64 0.52 
IKBKG 2.91 0.48 2.37 1.76 0.16 
Jnk 2.24 1.23 2.49 0.36 -2.12
IL5 3.02 0.69 3.00
JAK1 2.18 1.00 1.98 0.55 0.00 0.15 
IL6 3.47 0.70 1.16 0.77 0.52 -2.09
IL6R 0.17 0.65 2.75 0.28 0.97 0.55 
INS 1.29 1.66 0.03 0.70 0.01 
Ins1 0.27 1.50 2.23 0.02 -2.26
PDGF (family) 2.00





2.00 0.45 -2.14 0.60 
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Inosine 2.41 2.50 -2.41
Total activated upstream 103 46 70 48 18 18
























































The values show the activation Z-score. The absolute Z-scores ≥2 are in squares
ALDH1A2 aldehyde dehydrogenase 1 family, member A2, CHUK conserved helix-loop-helix ubiquitous kinase, ESR1 estrogen receptor 1, GCG glucagon, GDF2 growth
differentiation factor 2, HOXD3 homeobox D3, IKBKB inhibitor of kappa light polypeptide gene enhancer in B cells, kinase beta, IKBKG inhibitor of kappa light polypeptide
gene enhancer in B cells, kinase gamma, IL5 interleukin 5, IL6 interleukin 6, IL6R interleukin 6 receptor, INHA inhibin, alpha, INS insulin, Ins1 insulin I, JAK1 Janus kinase 1,
PDGF platelet-derived growth factor, TGFB1 transforming growth factor, beta 1




Five-week-old male ddY mice (SLC Japan, Shizuoka,
Japan) were housed in plastic cages with food (MF,Oriental yeast, Tokyo, Japan) and deionized water ad
libitum in a temperature- and humidity-controlled room
with a 12-h light/dark cycle (light 08:00–20:00; dark
20:00–08:00). The mice were weighed every day. All
animal experimental protocols were approved by the
Animal Use Committee of the Faculty of Agriculture at
the University of Tokyo with approval number: P12-669.
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Glycine and all L-amino acids were purchased from
Wako Pure Chemical Industries (Osaka, Japan). The
amino acid mixtures VAAM and CAAM were prepared
in the ratios described by Abe et al. [6] and were analyzed
for amino acid composition using a Hitachi L-8500A
amino acid analyzer (Hitachi High Technologies, Tokyo)
(Additional file 1: Table S1). The concentrations of VAAM
and CAAM were each adjusted to 1.8 %.
Experimental procedure
The experimental schedule is shown in Additional file 2:
Figure S1. The mice (n = 21) were acclimated to a la-
boratory environment for 1 week. They were divided
randomly into three treatment groups: VAAM, CAAM,
or water. Using a feeding tube, 1.8 % VAAM, 1.8 %
CAAM, or water was orally administered five times once
a day at 10:00AM. The dosage of VAAM, CAAM, or
water was adjusted to 37.5 μL per gram of body weight
as described previously [6]. On the day of last adminis-
tration, the food was removed and the mice were moved
to clean cages at 8:00. The last treatments began at
10:00. At 4 h after the last administration, the mice were
euthanized by cervical dislocation and the blood, liver,
WAT, and BAT were collected. The blood was separated
to obtain the serum. Small hepatic pieces were
immersed into RNAlater (Qiagen, Tokyo, Japan). The
WAT and BAT were immediately frozen after extraction
using liquid nitrogen. All samples were maintained at
−80 °C until use. Two mice in CAAM group were ex-
cluded because of their morphological abnormality in
the liver. Subsequently, the mice number of each group
became n = 7 for the VAAM group, n = 5 for the CAAM
group, and n = 7 for the water group.
Measurement of serum biochemical parameters
Serum glucose, non-esterified fatty acid (NEFA), and triac-
ylglycerol were enzymatically assayed using the glucose C
II test Wako, the NEFA C test Wako, and the triglyceride
E test Wako (Wako Pure Chemical Industries, Osaka,
Japan), respectively. Total lipids, total ketone bodies, total
cholesterol, HDL cholesterol and LDL cholesterol were
assayed on Nagahama Life Science (Shiga, Japan). Each of
the values is represented as the mean ± standard error of
the mean (SEM). Significant differences (p ≤ 0.05) between
the experimental groups were assessed by Tukey-Kramer
comparison.
DNA microarray assay
Total RNA was isolated from each hepatic, WAT, and
BAT sample by TRIzol reagent (Invitrogen Japan, Tokyo,
Japan) and purified using an RNeasy mini kit (Qiagen,
Tokyo, Japan). The RNA Integrity Number (RIN) was
estimated as an index of the quality of the total RNAusing an Agilent 2100 Bioanalyzer (Agilent Technologies
Japan, Tokyo, Japan). The values for RIN were over 8.3.
Then, amplified RNA (aRNA) was synthesized from
200 ng of purified total RNA, and biotinylated aRNA was
obtained using a GeneChip® 3′IVT Express Kit (Affymetrix,
Santa Clara, CA, USA). The aRNA was fragmented and hy-
bridized to a GeneChip® Mouse Genome 430 2.0 Array
(Affymetrix) for 16 h at 45 °C. The arrays were washed and
stained with phycoerythrin using the GeneChip® Fluidics
Station 450 (Affymetrix). The arrays were submitted to
scanning on an Affymetrix GeneChip® Scanner 3000 7G
(Affymetrix). The Affymetrix® GeneChip® Command Con-
sole® Software (Affymetrix) was used to make CEL files.
DNA microarray data analysis
The CEL files were quantified by the distribution free
weighted method (DFW) [19] using the statistical language
R (2.7.1) (http://www.r-project.org/) [20] and Bioconductor
(2.2) (http://www.bioconductor.org/) [21]. Hierarchical
clustering was performed using the pvclust() function in R
[22]. The rank products (RP) method was used to identify
differentially expressed gene probe sets of the DFW-
quantified data [23]. The probe sets with a false dis-
covery rate (FDR) <0.05 were considered to be differen-
tially expressed between two groups. RP was performed
for a comparison of the water treatment group and the
VAAM or CAAM treatment groups.
Gene ontology analysis
The up- and down-regulated probe sets picked out at
FDR <0.05 were functionally classified by the biological
process in gene ontology (GO) with the Functional Anno-
tation Tool of the Database for Annotation, Visualization,
and Integrated Discovery (DAVID) [24, 25] and Quick GO
(http://www.ebi.ac.uk/QuickGO/) [26]. EASE scores,
which are modified Fisher’s exact test p values, were used
to extract statistically overrepresented GO terms. GO
terms with FDR-corrected p values <0.01 were regarded as
significantly enriched.
Pathway analysis
The differentially expressed genes were mapped on
metabolic pathways in reference to the Kyoto Encyclopedia
of Genes and Genomes (www.genome.ad.jp/kegg) [27].
Upstream regulator analysis
Predicted upstream regulators from VAAM- and CAAM-
specific data sets were analyzed using QIAGEN’s Ingenuity®
Pathway Analysis (IPA®, QIAGEN Redwood City, www.qia-
gen.com/ingenuity). The activation Z-score was calculated
as a measure of upstream regulator analysis. An absolute
Z-score ≥2 was judged as significantly activated or inhib-
ited, while an absolute Z-score ≤1.0 could not judge a dir-
ection. Common upstream regulators that were predicted
Shinozaki et al. Genes & Nutrition  (2016) 11:21 Page 9 of 10to be activated or inhibited in the liver, WAT, and BAT
were selected from the all upstream regulators list.Quantitative PCR analysis
Total RNA was prepared as described in “DNA micro-
array assay” section. Complementary DNA (cDNA) was
synthesized with PrimeScript RT reagent kit (TaKaRa,
Shiga, Japan) and subjected to PCR analysis using the
following primer sets and SYBR Premix Ex Taq II kit
(TaKaRa). The cDNA was amplified by 30 s at 95 °C
followed by 40 cycles of incubation at 95 °C for 15 s and
at 60 °C for 30 s in CFX96 real-time PCR detection
system (Bio-Rad). The primers sets were as follows:
Elovl3 forward; 5′-TTCTCACGCGGGTTAAAAATG
G-3′, Elovl3 reverse; 5′- GAGCAACAGATAGACGAC
CAC-3′, G6pc forward; 5′-TTCAAGTGGATTCTGT
TTGG-3′, G6pc reverse; 5′- AGATAGCAAGAGTAG
AAGTGAC-3′, Pecr forward; 5′-GAAGGGATGGCA
TGCTGTGA-3′, Pecr reverse; 5′- TTGACAATCGAC
CCTCCGTG-3′, beta-actin forward; 5′-GATGTATGA
AGGCTTTGGTC-3′, beta-actin reverse; 5′- TGTGC
ACTTTTATTGGTCTC-3′. Each cycle threshold (CT)
value of an amplified fragment was compared with
that of beta-actin and represented as a relative ex-
pression level. Values for VAAM or CAAM treatment
group and water treatment group were examined for
their significant difference using Dunnett’s test.Additional files
Additional file 1: Table S1. Comparison of amino acid mixtures (Mol%).
The amino acid mixtures VAAM and CAAM were analyzed for amino acid
composition using an amino acid analyzer. (DOCX 36 kb)
Additional file 2: Figure S1. Feeding schedule of amino acid mixtures.
VAAM, CAAM or water was orally administered five times once a day
using a feeding tube. Daily administration was performed at 10:00. On
the day of last administration, the food was removed and the mice
were moved to clean cages at 8:00. The last treatments began at 10:00.
At 4 hours after the last administration, the mice were euthanized by
cervical dislocation and blood, liver, WAT and BAT were collected.
(PPTX 53 kb)
Additional file 3: Table S2. Serum biomedical indices of mice
administrated amino acid mixtures. The values are represented as the
mean ± standard error of the mean (SEM). (DOCX 26 kb)
Additional file 4: Table S3. The list of liver genes showing significant
enrichment in the GO-terms located at the bottom of the hierarchy.
VAAM-specific genes mapped on Figure 3 were represented by bold
style. (XLSX 11 kb)
Additional file 5: Table S4. Genes mapped on Fig. 3. (XLSX 13 kb)
Additional file 6: Figure S2. The relative hepatic mRNA expression
levels of Elovl3, G6pc, and Pecr in VAAM, CAAM or Water group.
Quantitative PCR analysis were performed to validate the expression of
metabolic genes, Elovl3 (elongation of very long chain fatty acids like 3), Pecr
(peroxisomal trans-2-enoyl-CoA reductase) and G6pc (glucose-6-phosphatase,
catalytic subunit) in Water and VAAM or CAAM groups. *: p≤ 0.05 by
Dunnett’s test. (PPTX 69 kb)
Additional file 7: Table S5. The list of WAT genes showing significant
enrichment in the GO-terms located at the bottom of the hierarchy.VAAM-specific genes mapped on Figure 3 were represented by bold
style. (XLSX 11 kb)
Additional file 8: Table S6. The list of BAT genes showing significant
enrichment in the GO-terms located at the bottom of the hierarchy. The
list of BAT genes showing significant enrichment in the GO-terms located
at the bottom of the hierarchy. (XLSX 12 kb)
Abbreviations
BAT, brown adipose tissue; CAAM, casein amino acid mixture; EAAs, essential
amino acids; NEFA, non-esterified fatty acid; VAAM, Vespa amino acid mixture;
WAT, white adipose tissue
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